Is Pliant TherapeuticsInc Stock a Good Investment?
Pliant TherapeuticsInc Investment Advice | PLRX |
- Examine Pliant TherapeuticsInc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Pliant TherapeuticsInc's leadership team and their track record. Good management can help Pliant TherapeuticsInc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Pliant TherapeuticsInc's business and its evolving consumer preferences.
- Compare Pliant TherapeuticsInc's performance and market position to its competitors. Analyze how Pliant TherapeuticsInc is positioned in terms of product offerings, innovation, and market share.
- Check if Pliant TherapeuticsInc pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Pliant TherapeuticsInc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Pliant TherapeuticsInc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Pliant TherapeuticsInc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Pliant TherapeuticsInc Stock
Researching Pliant TherapeuticsInc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.8. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pliant TherapeuticsInc recorded a loss per share of 2.86. The entity had not issued any dividends in recent years.
To determine if Pliant TherapeuticsInc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Pliant TherapeuticsInc's research are outlined below:
Pliant TherapeuticsInc generated a negative expected return over the last 90 days | |
Pliant TherapeuticsInc has high historical volatility and very poor performance | |
The company reported the previous year's revenue of 1.58 M. Net Loss for the year was (161.34 M) with profit before overhead, payroll, taxes, and interest of 9.69 M. | |
Pliant TherapeuticsInc currently holds about 163.6 M in cash with (116.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.36. | |
Over 93.0% of the company shares are owned by institutional investors | |
Latest headline from investorplace.com: PLRX Stock Earnings Pliant Therapeutics Misses EPS for Q1 2024 |
Pliant TherapeuticsInc Quarterly Cash And Short Term Investments |
|
Pliant TherapeuticsInc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Pliant TherapeuticsInc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pliant TherapeuticsInc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of March 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
14th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Pliant TherapeuticsInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Pliant TherapeuticsInc's investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-02-28 | 2021-12-31 | -0.76 | -0.68 | 0.08 | 10 | ||
2022-11-08 | 2022-09-30 | -0.74 | -0.65 | 0.09 | 12 | ||
2024-02-13 | 2023-12-31 | -0.81 | -0.69 | 0.12 | 14 | ||
2021-03-16 | 2020-12-31 | -0.71 | -0.54 | 0.17 | 23 | ||
2020-11-10 | 2020-09-30 | -0.85 | -0.47 | 0.38 | 44 | ||
2020-08-11 | 2020-06-30 | -0.77 | -1.39 | -0.62 | 80 |
Pliant TherapeuticsInc Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pliant target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Pliant TherapeuticsInc's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
14 | Strong Buy |
Most Pliant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Pliant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Pliant TherapeuticsInc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPliant TherapeuticsInc Target Price Projection
Pliant TherapeuticsInc's current and average target prices are 13.79 and 46.57, respectively. The current price of Pliant TherapeuticsInc is the price at which Pliant TherapeuticsInc is currently trading. On the other hand, Pliant TherapeuticsInc's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Pliant TherapeuticsInc Market Quote on 8th of May 2024
Target Price
Analyst Consensus On Pliant TherapeuticsInc Target Price
Pliant TherapeuticsInc Analyst Ratings
Pliant TherapeuticsInc's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Pliant TherapeuticsInc stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Pliant TherapeuticsInc's financials, market performance, and future outlook by experienced professionals. Pliant TherapeuticsInc's historical ratings below, therefore, can serve as a valuable tool for investors.Know Pliant TherapeuticsInc's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Pliant TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pliant TherapeuticsInc backward and forwards among themselves. Pliant TherapeuticsInc's institutional investor refers to the entity that pools money to purchase Pliant TherapeuticsInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Polar Capital Holdings Plc | 2023-12-31 | 2 M | Great Point Partners Llc | 2023-12-31 | 1.8 M | Franklin Resources Inc | 2023-12-31 | 1.6 M | Casdin Capital, Llc | 2023-12-31 | 1.6 M | Citadel Advisors Llc | 2023-09-30 | 1.5 M | State Street Corporation | 2023-12-31 | 1.3 M | Pictet Asset Manangement Sa | 2023-12-31 | 1.3 M | Ra Capital Management, Llc | 2023-12-31 | 1.3 M | Geode Capital Management, Llc | 2023-12-31 | 1.2 M | Deep Track Capital, Lp | 2023-12-31 | 5.8 M | Blackrock Inc | 2023-12-31 | 4.8 M |
Pliant TherapeuticsInc's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 831.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pliant TherapeuticsInc's market, we take the total number of its shares issued and multiply it by Pliant TherapeuticsInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Pliant TherapeuticsInc's profitablity analysis
Pliant TherapeuticsInc's profitability indicators refer to fundamental financial ratios that showcase Pliant TherapeuticsInc's ability to generate income relative to its revenue or operating costs. If, let's say, Pliant TherapeuticsInc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pliant TherapeuticsInc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pliant TherapeuticsInc's profitability requires more research than a typical breakdown of Pliant TherapeuticsInc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.32) | (0.33) | |
Return On Capital Employed | (0.38) | (0.40) | |
Return On Assets | (0.32) | (0.33) | |
Return On Equity | (0.34) | (0.32) |
Determining Pliant TherapeuticsInc's profitability involves analyzing its financial statements and using various financial metrics to determine if Pliant TherapeuticsInc is a good buy. For example, gross profit margin measures Pliant TherapeuticsInc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Pliant TherapeuticsInc's profitability and make more informed investment decisions.
The data published in Pliant TherapeuticsInc's official financial statements usually reflect Pliant TherapeuticsInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Pliant TherapeuticsInc. For example, before you start analyzing numbers published by Pliant accountants, it's critical to develop an understanding of what Pliant TherapeuticsInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Pliant TherapeuticsInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pliant TherapeuticsInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Pliant TherapeuticsInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pliant TherapeuticsInc. Please utilize our Beneish M Score to check the likelihood of Pliant TherapeuticsInc's management manipulating its earnings.
Evaluate Pliant TherapeuticsInc's management efficiency
Pliant TherapeuticsInc has return on total asset (ROA) of (0.2171) % which means that it has lost $0.2171 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3417) %, meaning that it created substantial loss on money invested by shareholders. Pliant TherapeuticsInc's management efficiency ratios could be used to measure how well Pliant TherapeuticsInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.33 in 2024. Return On Capital Employed is likely to drop to -0.4 in 2024. At this time, Pliant TherapeuticsInc's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 378.4 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 8.07 | 8.47 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 8.07 | 8.47 | |
Enterprise Value Over EBITDA | (5.55) | (5.83) | |
Price Book Value Ratio | 2.25 | 2.36 | |
Enterprise Value Multiple | (5.55) | (5.83) | |
Price Fair Value | 2.25 | 2.36 | |
Enterprise Value | 1 B | 528.7 M |
The analysis of Pliant TherapeuticsInc's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Pliant TherapeuticsInc's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Pliant Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.125 |
Basic technical analysis of Pliant Stock
As of the 8th of May, Pliant TherapeuticsInc holds the Coefficient Of Variation of (1,251), variance of 12.91, and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pliant TherapeuticsInc, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Pliant TherapeuticsInc, which can be compared to its competitors. Please check Pliant TherapeuticsInc standard deviation and potential upside to decide if Pliant TherapeuticsInc is priced some-what accurately, providing market reflects its current price of 13.79 per share. Given that Pliant TherapeuticsInc has information ratio of (0.10), we recommend you to check out Pliant TherapeuticsInc's recent market performance to make sure the company can sustain itself at a future point.Pliant TherapeuticsInc's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pliant TherapeuticsInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pliant TherapeuticsInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pliant TherapeuticsInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Pliant TherapeuticsInc's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Pliant TherapeuticsInc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | (0.04) | |||
Market Risk Adjusted Performance | 0.6773 | |||
Mean Deviation | 2.71 | |||
Coefficient Of Variation | (1,251) | |||
Standard Deviation | 3.59 | |||
Variance | 12.91 | |||
Information Ratio | (0.10) | |||
Jensen Alpha | (0.27) | |||
Total Risk Alpha | (0.67) | |||
Treynor Ratio | 0.6673 | |||
Maximum Drawdown | 15.73 | |||
Value At Risk | (6.55) | |||
Potential Upside | 4.66 | |||
Skewness | (0.41) | |||
Kurtosis | 1.22 |
Risk Adjusted Performance | (0.04) | |||
Market Risk Adjusted Performance | 0.6773 | |||
Mean Deviation | 2.71 | |||
Coefficient Of Variation | (1,251) | |||
Standard Deviation | 3.59 | |||
Variance | 12.91 | |||
Information Ratio | (0.10) | |||
Jensen Alpha | (0.27) | |||
Total Risk Alpha | (0.67) | |||
Treynor Ratio | 0.6673 | |||
Maximum Drawdown | 15.73 | |||
Value At Risk | (6.55) | |||
Potential Upside | 4.66 | |||
Skewness | (0.41) | |||
Kurtosis | 1.22 |
Consider Pliant TherapeuticsInc's intraday indicators
Pliant TherapeuticsInc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pliant TherapeuticsInc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 26990.08 | |||
Daily Balance Of Power | (0.16) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 13.53 | |||
Day Typical Price | 13.62 | |||
Price Action Indicator | 0.16 | |||
Period Momentum Indicator | (0.19) | |||
Relative Strength Index | 32.25 |
Pliant TherapeuticsInc Corporate Filings
F4 | 6th of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
22nd of April 2024 Other Reports | ViewVerify | |
8K | 12th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Pliant Stock media impact
Far too much social signal, news, headlines, and media speculation about Pliant TherapeuticsInc that are available to investors today. That information is available publicly through Pliant media outlets and privately through word of mouth or via Pliant internal channels. However, regardless of the origin, that massive amount of Pliant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pliant TherapeuticsInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pliant TherapeuticsInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pliant TherapeuticsInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pliant TherapeuticsInc alpha.
Pliant TherapeuticsInc Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pliant TherapeuticsInc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pliant TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Pliant TherapeuticsInc Corporate Management
Elected by the shareholders, the Pliant TherapeuticsInc's board of directors comprises two types of representatives: Pliant TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pliant. The board's role is to monitor Pliant TherapeuticsInc's management team and ensure that shareholders' interests are well served. Pliant TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pliant TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA | Chief Officer | Profile | |
Hal MD | Scientific Board | Profile | |
Mike Ouimette | Gen Sec | Profile | |
Rik Derynck | Scientific Board | Profile | |
Dean MD | Scientific Board | Profile | |
Johannes Hull | Chief Officer | Profile | |
ric MD | Chief Officer | Profile |
How to buy Pliant Stock?
To provide specific investment advice or recommendations on Pliant TherapeuticsInc stock, we recommend investors consider the following general factors when evaluating Pliant TherapeuticsInc. This will help you to make an informed decision on whether to include Pliant TherapeuticsInc in one of your diversified portfolios:- Examine Pliant TherapeuticsInc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Pliant TherapeuticsInc's leadership team and their track record. Good management can help Pliant TherapeuticsInc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Pliant TherapeuticsInc's business and its evolving consumer preferences.
- Compare Pliant TherapeuticsInc's performance and market position to its competitors. Analyze how Pliant TherapeuticsInc is positioned in terms of product offerings, innovation, and market share.
- Check if Pliant TherapeuticsInc pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Pliant TherapeuticsInc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Pliant TherapeuticsInc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Pliant TherapeuticsInc is a good investment.
Already Invested in Pliant TherapeuticsInc?
The danger of trading Pliant TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pliant TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pliant TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pliant TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pliant TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pliant TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pliant Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pliant Therapeuticsinc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Pliant TherapeuticsInc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.